U.S. regulators have authorized a second pill against COVID-19, an antiviral drug from Merck that may help blunt the wave of infections driven by the omicron variant
Related posts
-
Cubs wary of unfriendly wind holding back Tucker
The winds of Wrigley Field are historically tougher on left-handed hitters. That’s a concern this season... -
‘His passion was for Woodridge’: Village mourns longtime mayor
Among DuPage County’s fraternity of past mayors, few had as long and as fruitful a career... -
‘What’s not to like about a healthy lake?’: Pilot monitoring program launched in Lake County
A volunteer group’s passion enters a new phase this weekend with the start of a pilot...